On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Sunesis (United States)

InstitutionResearch output, impact & collaborations

Sunesis (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Sunesis (United States)?

ScholarIQrecord summary

Sunesis (United States) is a research organisation in South San Francisco, US. OpenAlex records 2,167 works and 696,268 citations for it. 865 researchers list it as their most recent affiliation.

How many works does Sunesis (United States) have?

ScholarIQindexed works

Sunesis (United States) has 2,167 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Sunesis (United States) have?

ScholarIQcitation count

Sunesis (United States) has 696,268 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Sunesis (United States)?

ScholarIQresearcher count

Sunesis (United States) has 865 researchers in the ScholarIQ index.

What is the average h-index at Sunesis (United States)?

ScholarIQavg h-index

Sunesis (United States) has an average h-index of 46.7 in OpenAlex.

What is the ROR of Sunesis (United States)?

ScholarIQror

The ROR for Sunesis (United States) is on the source record.

What is the OpenAlex record for Sunesis (United States)?

ScholarIQopenalex

The OpenAlex for Sunesis (United States) is on the source record.

Who are the most-cited researchers behind Sunesis (United States)?

ScholarIQtop researchers by citations
1
Bernard Levin · Colorectal Cancer Screening and Detection
256 works18,452 citations
2
David C. Spellmeyer · Computational Drug Discovery Methods
97 works17,588 citations
3
Lori S. Friedman · PI3K/AKT/mTOR signaling in cancer
296 works16,231 citations

What are the most-cited papers on Sunesis (United States)?

ScholarIQmost cited works
First-in-Human Phase I Study of Pictilisib (GDC-0941), a Potent Pan–Class I Phosphatidylinositol-3-Kinase (PI3K) Inhibitor, in Patients with Advanced Solid Tumors
Debashis Sarker, Joo Ern Ang, Richard D. Baird, Rebecca Kristeleit, Krunal Shah, Víctor Moreno, Paul A. Clarke, Florence I. Raynaud, Gallia G. Levy, Joseph A. Ware, Kathryn Mazina, Ray Lin, Jenny Wu, Jill Fredrickson, Jill M. Spoerke, Mark R. Lackner, Yibing Yan, Lori S. Friedman, Stan B. Kaye, Mika K. Derynck, Paul Workman, Johann S. de Bono
Clinical Cancer Research. 2014362 CitationsOPEN ACCESS
Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward
Gary J. Kelloff, Scott M. Lippman, Andrew J. Dannenberg, Caroline C. Sigman, Homer L. Pearce, Brian J. Reid, Éva Szabó, V. Craig Jordan, Margaret R. Spitz, Gordon B. Mills, Vali A. Papadimitrakopoulou, Reuben Lotan, Bharat B. Aggarwal, Robert S. Bresalier, Jeri Kim, Banu Arun, Karen H. Lu, Melanie E. Thomas, Helen Rhodes, Molly Brewer, Michele Follen, Dong M. Shin, Howard L. Parnes, Jill M. Siegfried, Alison A. Evans, William J. Blot, Wong‐Ho Chow, Patricia L. Blount, Carlo C. Maley, Kenneth K. Wang, Stephen Lam, J. Jack Lee, Steven M. Dubinett, Paul F. Engstrom, Frank L. Meyskens, Joyce O’Shaughnessy, Ernest T. Hawk, Bernard Levin, William G. Nelson, Waun Ki Hong, for the AACR Task Force on Cancer Prevention
Clinical Cancer Research. 2006271 CitationsOPEN ACCESS
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
Emily J. Hanan, Marie-Gabrielle Braun, Robert A. Heald, Calum MacLeod, Connie Chan, Saundra Clausen, Kyle A. Edgar, Charles Eigenbrot, Richard L. Elliott, Nicholas Endres, Lori S. Friedman, Emily Gogol, Xiaohui Gu, Rebecca Hong Thibodeau, Philip S. Jackson, James R. Kiefer, Jamie D. Knight, Michelle Nannini, Raman Narukulla, Amanda F. Pace, Jodie Pang, Hans E. Purkey, Laurent Salphati, Deepak Sampath, Stephen Schmidt, Steve Sideris, Kyung Song, Swathi Sujatha-Bhaskar, Mark Ultsch, Heidi J.A. Wallweber, Jianfeng Xin, SiewKuen Yeap, Amy Young, Yu Zhong, Steven T. Staben
Journal of Medicinal Chemistry. 2022139 CitationsOPEN ACCESS

How much of the research on Sunesis (United States) is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
0%
Bronze
67%
Closed
0%

Related on ScholarIQ

470M+ articles · 14-day free trial